Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023Senores-new-logo-Oct-2023
  • About Us
    • About Senores
    • Milestone
    • Leadership
    • Partnership
    • Corporate Film
  • Manufacturing
    • Formulations
    • API
  • Products
    • Formulation – Regulated Market
    • Formulation – Emerging Market
    • API
    • Critical Care – Hospital Line
    • Private Label
  • R&D
  • Investors
    • Offer Documents
    • Financials
    • Policies
    • Reports
    • Shareholding Pattern
    • Committees
    • Investor Contacts
    • Announcements
    • Corporate Governance Reports
    • Investor Meet
    • MOA-AOA
    • Reg. 46 of SEBI (LODR) Regulations
  • Contact

Announcements
KMPs Authorised to Determine Materiality
Trading Window Closure - 31.12.2024
Media Release - 09.01.2025
Intimation of Board Meeting - 10.01.2025
Intimation for Earnings Call
Intimation for Investment in Subsidiary - 20.01.2025
Intimation of Media Release - 23.01.2025
Outcome of Board Meeting - 23.01.2025
Statement of Deviation and Variation - 23.01.2025
Intimation for Investor Presentation - 23.01.2025
Intimation for Appointment of Secretarial Auditor - 23.01.2025
Intimation for Monitoring Agency Report - 23.01.2025
Integrated Filing - Financials - 23.01.2025
Intimation regarding Outcome of Earnings Conference Call - 23.01.2025
Intimation for Newspaper Publication - 24.01.2025
Intimation for Transcript of Earnings Conference Call
Intimation for Investor Meet - 06.02.2025 & 07.02.2025
Intimation regarding change of domain name of RTA - 18.02.2025
Media Release - 20.02.2025
Media Release - 26.02.2025
Media Release - 04.03.2025
Intimation for Investor Meet - 06.03.2025
Intimation for share acquisition of Havix - 11.03.2025
Additional Disclosure regarding Acquisition - Havix - 12.03.2025
Intimation for investment in WOS - 20.03.2025
Trading Window Closure - 27.03.2025
Intimation for Corporate Guarantee - 02.04.2025
Intimation for Investor Meeting - 03.04.2025
Intimation for Update in MCA Master Data - 04.04.2025
Intimation regarding change in contact details of RTA - 19.04.2025
Updates on Acquisition of Shares of Havix - 22.04.2025
Intimation under Regulation 30 - 02.05.2025
Media Release - 05.05.2025
Media Release - 09.05.2025
Intimation of Board Meeting - 09.05.2025
Intimation for Earnings Call - 12.05.2025
Outcome of Board Meeting - 15.05.2025
Intimation of Media Release - 15.05.2025
Intimation for Appointmnet of Secretarial Auditor - 15.05.2025
Intimation for Changes in Senior Managerial Personnel - 15.05.2025
Intimation for Monitoring Agency Report - 15.05.2025
Intimation for Investor Presentation - 16.05.2025
Intimation for Newspaper Publication - 16.05.2025
Intimation regarding Outcome of Earnings Conference Call - 16.05.2025
Media Release - 20.05.2025
Intimation for Transcript of Earnings Conference Call-22.05.2025
Intimation for appointment of Internal Auditors - 02.06.2025
Outcome of Board Meeting - 02.06.2025
Intimation for Investor Meeting - 18.06.2025
Updates on Acquisition of Shares of Havix - 23.06.2025
Trading Window Closure - 25.06.2025
Intimation for Share acquisition of Havix - 10.07.205
Intimation for Corporate Guarantee - 10.07.2025
Intimation of Board Meeting - 17.07.2025
Intimation for Earnings Conference Call - 19.07.2025
Outcome of Board Meeting - 23.07.2025
Intimation for change in SMP - 23.07.2025
Financial Results for Q1 FY2025-26 - 23.07.2025
Intimation for Media Release - 23.07.2025
Intimation for Monitoring Agency Report - 23.07.2025
Intimation for Investor Presentation - 23.07.2025
Intimation for Newspaper Publication - 24.07.2025
Outcome of Earnings Call - 24.07.2025
Intimation for Completion of USFDA Inspection at Havix
Intimation Transcript of Earnings Call - 30.07.2025
Intimation for Investor Meeting - 05.08.2025
Media Release - 12.08.2025
Intimation for Investor Meeting - 13.08.2025
Intimation for cancellation of Participation in Meet - 19.08.2025
Notice of Eighth (8th) AGM
Intimation for Investor Meeting - 28.08.2025
Intimation for Newspaper Publication - 28.08.2025
Intimation for Re-scheduling of Investor Meeting - 02.09.2025
Intimation for Corrigendum to the Annual Report - 05.09.2025
Updates on Acquisition of Shares of Havix - 12.09.2025
Intimation for Investment in WOS - 18.09.2025
Proceedings of 08th AGM
Scrutinizer Report and Voting Results for 08th AGM
Trading Window Closure - 26.09.2025
Intimation regarding change in E-mail Address of RTA - 08.10.2025

Useful Links

  • About Us
  • Manufacturing
  • Products
  • Partnership
  • R&D
  • Regulatory
  • Adverse Drug Reaction Reporting Form
  • Media
  • Career
  • Contact

Disclaimer

• All the information present on Senores Pharmaceuticals website is not applicable to all the countries across the world. The  purpose  of   this  website is to provide information about Senores Pharmaceuticals' products and services. Any information present on the website shouldn't be misused or construed to spread or promote any of the products in the countries where are disapproved or prohibited.
• Listed  products  in this website will not be supplied to countries in which these could be in conflict with existing valid patents. The buyers should make their independent evaluation of the patent scenario for their respective market as the final responsibility lies exclusively with the buyer.
• Patented products will only be supplied for development, testing, and regulatory submission purposes.

© 2023 Senores Pharmaceuticals | All Rights Reserved.